No association of GBA mutations and multiple system atrophy

European Journal of Neurology

Volumn 20, Issue 4, 2013, Pages

  Srulijes, K ^a,b   Hauser, A K ^a,b   Guella, I ^c   Asselta, R ^c   Brockmann, K ^a,b   Schulte, C ^a,b   Solda G ^c   Cilia, R ^d   Maetzler, W ^a,b,e   Schols, L ^a,b   Wenning, G K ^f   Poewe, W ^f   Barone, P ^g   Wullner U ^h   Oertel, W ⁱ   Berg, D ^a,b   Goldwurm, S ^d   Gasser, T ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c UNIVERSITY OF MILAN   (Italy)

^d PARKINSON INSTITUTE   (Italy)

^e ROBERT BOSCH HOSPITAL   (Germany)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^g UNIVERSITY OF SALERNO   (Italy)

^h UNIVERSITY HOSPITAL BONN   (Germany)

ⁱ PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Glucocerebrosidase; Multiple system atrophy; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; GLUCOSYLCERAMIDASE;

ADULT; AGED; EXON; GENE MUTATION; HEREDITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MUTATION RATE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN AGGREGATION; SHY DRAGER SYNDROME;

COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOME-WIDE ASSOCIATION STUDY; GLUCOSYLCERAMIDASE; HUMANS; MULTIPLE SYSTEM ATROPHY; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84875020947     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12086     Document Type: Letter

References (10)

1. Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009; 361: 1651-1661.
2. Brockmann K, Srulijes K, Hauser AK, et al. GBA-associated PD presents with nonmotor characteristics. Neurology 2011; 77: 276-280.
3. Neumann J, Bras J, Deas E, et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 2009; 132: 1783-1794.
4. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71: 670-676.
5. Walker JM, Lwin A, Tayebi N, LaMarca ME, Orvisky E, Sidransky E. Glucocerebrosidase mutation T369M appears to be another polymorphism. Clin Genet 2003; 63: 237-238.
6. Goker-Alpan O, Giasson BI, Eblan MJ, et al. Glucocerebrosidase mutations are an important risk factor for Lewy body disorders. Neurology 2006; 67: 908-910.
7. Segarane B, Li A, Paudel R, et al. Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology 2009; 72: 1185-1186.
8. Nishioka K, Ross OA, Vilarino-Guell C, et al. Glucocerebrosidase mutations in diffuse Lewy body disease. Parkinsonism Relat Disord 2011; 17: 55-57.
9. Scholz SW, Houlden H, Schulte C, et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009; 65: 610-614.
10. Goker-Alpan O, Stubblefield BK, Giasson BI, Sidransky E. Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders. Acta Neuropathol 2010; 120: 641-649.